Form 8-K - Current report:
SEC Accession No. 0001193125-21-196269
Filing Date
2021-06-22
Accepted
2021-06-22 16:31:32
Documents
12
Period of Report
2021-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d134534d8k.htm   iXBRL 8-K 36388
  Complete submission text file 0001193125-21-196269.txt   155590

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bbio-20210617.xsd EX-101.SCH 2883
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bbio-20210617_lab.xml EX-101.LAB 17374
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bbio-20210617_pre.xml EX-101.PRE 10947
5 EXTRACTED XBRL INSTANCE DOCUMENT d134534d8k_htm.xml XML 3205
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38959 | Film No.: 211035720
SIC: 2834 Pharmaceutical Preparations